References
  1. Fajgenbaum DC, Uldrick TS Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease.Blood. 2017; 129(12): 1646-1657.
  2. Tobias B, Maxime V, Martin J, Tobias S, Frank S, et al. Case report: Covd-19 vaccination-related cerebral venous thrombosis and thrombotic thrombocytopenia syndrome. Front Neurol. 2021; 22;12:763049.
  3. Yongwhan L, Min CK, Kye HK, In-Seok J, Yong SC, Yoo DC, Jong EL. Case report: Acute fulminant myocarditis and cardiogenic shock after messenger RNA coronavirus disease 2019 vaccination requiring extracorporeal cardiopulmonary resuscitation. Front Cardiovasc Med . 2021; 29;8:758996.
  4. Tan HZ, Tan RY, Choo JCJ, Lim CC, Tan CS, et al. Is COVID-19 vaccination unmasking glomerulonephritis? Kidney Int. 2021; 100(2):469-471.
  5. Lebedev L, Sapojnikov M, Wechsler A, Varadi-Levi R, Zamir D, et al. Minimal change disease Following the Pfizer-BioNTech COVID-19 Vaccine.Am J Kidney Dis. 2021; 78(1):142-145.
  6. D’Agati VD, Kudose S, Bomback AS, Adamidis A, Tartini A, et al. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 Vaccine. Kidney Int. 2021; 100(2):461-463.
  7. Komaba H, Wada T, Fukagawa M. Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. Am J Kidney Dis . 2021; 78(3):469-470.
  8. Masset C, Kervella D, Kandel-Aznar C, Fantou A, Bllancho G, et al. Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine.Kidney Int. 2021; 100(2):465-466.
  9. Hiroki MIzuno, Naoki Sawa, Shun Watanabe, Daisuke Ikuma, Akinari Seikne, Masahiro Kawada, et al. The clinical and histopathological feature of renal manifestation of TAFRO syndeome. Kidney International Rep. 2020; 5(8):1172-1179.
  10. Mansoor Radwi, Sara Farsi. A case report of acquired hemophilia following Covid-19 vaccine. J Thromb Haemost. 2021; 19(6):1515-1518.
  11. Iwaki N, Fajgenbaum DC, Nabel CS, et al. Clinicopathologic analysis of TAFRO syndrome demonstrates a distinct subtyoe of HHV-8-negative multicentric Castleman disease. Am J Hematol. 2016; 91(2):220-6.
  12. Shoko N, Keiichi S, Akinari S, et al. TAFRO syndrome with refractory thrombocytopenia responding to tocilizumab and romiplostim. CEN Case Rep. 2018; 7(1):162-168.
  13. Kentaro S, Kengo M, Mikio T. TAFRO syndrome: current perspectives.J Blood Med. 2018; 22;9:15-23.